Seaport Therapeutics SPTX
NASDAQ SPTX
$19.12 -0.86 (-4.30%)
At close: Nov 16, 2026 · 4:00 PM EST

Seaport Therapeutics (SPTX) Research & Development (2025 - 2026)

Updated

Seaport Therapeutics' Research & Development came in at $23.89 million for Q3 2026, up 16.8% from $20.45 million a year earlier but down 3.0% from the prior quarter.

Analysis

Seaport Therapeutics (SPTX) Research & Development (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Seaport Therapeutics reported Research & Development of $90.39 million.

  • The five-year range for quarterly Research & Development is $10.53 million (Q1 2025) to $24.62 million (Q2 2026).
  • Year-over-year, Research & Development has increased for three consecutive quarters.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 4.25 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 4.65 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 2.57 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 4.54 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 3.89 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 2.11 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 1.61 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 3.02 Bn
10 Seaport Therapeutics 1.03 Bn 63.31 Mn - 23.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 23.89 Mn
Jun 30, 2026 24.62 Mn
Mar 31, 2026 21.43 Mn
Sep 30, 2025 20.45 Mn
Jun 30, 2025 13.41 Mn
Mar 31, 2025 10.53 Mn
API Access

Seaport Therapeutics Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=SPTX&period=max&api_key=YOUR_API_KEY